siltuximab

J&J’s Drug Shows Promise for Rare Castleman Disease
Bloomberg
Sun, 12/8/13 - 12:20 pm
JNJ
siltuximab
multicentric Castleman disease
Simultaneous Applications Submitted to EMA and FDA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder
Reuters
Tue, 09/3/13 - 10:43 am
EMA
FDA
siltuximab
multicentric Castleman disease